Skip to main content

Advertisement

SpringerLink
Log in

Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The development of Alzheimer's disease (AD) has been strongly linked to the apolipoprotein E (APOE) polymorphism. A number studies have reported that the APOE ε4 allele is a genetic risk factor for developing AD, whereas the APOE ε2 and APOE ε3 alleles are considered to be neutral or even protective; however, there are conflicting data about these relationships in certain ethnic populations. Several meta-analyses have been performed to reduce the heterogeneity of results from different studies and estimate the real association in specific ethnicities. The aim of this study was to investigate the association between the APOE polymorphism and AD in an Iranian population. Our results showed a higher incidence of AD among individuals carrying the APOE ε4 allele (OR = 4.81, 95% CI: 3.28–7.05), more notably in those with the APOE ε4/e4 genotype (OR = 7.47, 95% CI: 2.35–23.73), while carrying the APOE ε3 allele was demonstrated to have a protective effect (OR = 0.40, 95% CI: 0.30–0.54). The association between the APOE ε2 allele and AD was not statically significant. However, further studies focusing on other parameters such as age, sex and environmental conditions are needed to reveal the true association between the APOE polymorphism and AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Agarwal R, Tripathi CB (2014) Association of apolipoprotein E genetic variation in Alzheimer’s disease in Indian population: a meta-analysis. Am J Alzheimers Dis Other Dement 29:575–582

    Article  Google Scholar 

  • Alzheimer's Association (2013) 2013 Alzheimer's disease facts and figures. Alzheimers Dement 9:208–245

    Article  Google Scholar 

  • Basak JM, Verghese PB, Yoon H, Kim J, Holtzman DM (2012) Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes. J Biol Chem M111:288746

    Google Scholar 

  • Bayrami M, Hashemi T, Bonyadi M, Ayromlou H, Nazari M, Tabatabaei S (2011) Apolipoprotein E gene polymorphism in Alzheimer patients in northwest of Iran. Aust J Basic Appl Sci 5:1729–1733

    CAS  Google Scholar 

  • Berlau DJ, Corrada MM, Head E, Kawas CH (2009) APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology 72:829–834

    Article  CAS  Google Scholar 

  • Bezprozvanny I (2009) Amyloid goes global. Sci Signal 2:pe16-pe16

    Article  Google Scholar 

  • Castellano JM et al (2011) Human APOE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med 3:89ra57-89ra57

    Article  Google Scholar 

  • Chartier-Hariln M-C et al (1994) Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13. 2 chromosomal region. Hum Mol Genet 3:569–574

    Article  Google Scholar 

  • Dodart J-C, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM (2005) Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci 102:1211–1216

    Article  CAS  Google Scholar 

  • Farrer LA et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Jama 278:1349–1356

    Article  CAS  Google Scholar 

  • Ghayeghran AR, Akbarshahi M, Salehi Z, Davoudi-Kiakalayeh A (2017) Analysis of apolipoprotein E genetic variation in patients with Alzheimer disease referred to Imam Reza Clinic, Rasht, Iran, in 2015. Iran J Neurol 16:173

    PubMed  PubMed Central  Google Scholar 

  • Giacobini E, Gold G (2013) Alzheimer disease therapy—moving from amyloid-β to tau. Nat Rev Neurol 9:677

    Article  CAS  Google Scholar 

  • Gureje O et al (2006) APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians. Ann Neurol 59:182–185

    Article  Google Scholar 

  • Harris FM et al (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci 100:10966–10971

    Article  CAS  Google Scholar 

  • Holtzman DM et al (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci 97:2892–2897

    Article  CAS  Google Scholar 

  • Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis 72:3–12

    Article  CAS  Google Scholar 

  • Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11:193

    Article  Google Scholar 

  • Iqbal K et al (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta (BBA)-Mol Basis Dis 1739:198–210

    Article  CAS  Google Scholar 

  • Jack CR Jr et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:257–262

    Article  Google Scholar 

  • Jiang Q et al (2008) APOE promotes the proteolytic degradation of Aβ. Neuron 58:681–693

    Article  CAS  Google Scholar 

  • Khorshid HK, Gozalpour E, Kamali K, Ohadi M, Karimloo M, Shahhosseiny M (2011) The association between sporadic Alzheimer’s disease and the human ABCA1 and APOE gene polymorphisms in Iranian population. Iran Red Crescent Med J 13:256

    Google Scholar 

  • Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63:287–303

    Article  CAS  Google Scholar 

  • Lee CD, Tse W, Smith JD, Landreth GE (2012) Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem 287:2032–2044

    Article  CAS  Google Scholar 

  • Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106

    Article  CAS  Google Scholar 

  • Liu M, Bian C, Zhang J, Wen F (2014) Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis. Sci Rep 4:4383

    Article  Google Scholar 

  • Mak Y et al (1996) Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 46:146–149

    Article  CAS  Google Scholar 

  • Montufar S et al. (2017) Association between the APOE ε4 allele and late-onset Alzheimer’s disease in an Ecuadorian mestizo population. Int J Alzheimer’s Dis 2017

  • Rajabli F et al (2018) Ancestral origin of APOE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet 14:e1007791

    Article  Google Scholar 

  • Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T (2005) Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 375:1–6

    Article  CAS  Google Scholar 

  • Seet WT, Anne TJAM, Yen TS (2004) Apolipoprotein E genotyping in the Malay, Chinese and Indian ethnic groups in Malaysia—a study on the distribution of the different APOE alleles and genotypes. Clin Chim Acta 340:201–205

    Article  Google Scholar 

  • Singh P, Singh M, Mastana S (2006) APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 33:279–308

    Article  CAS  Google Scholar 

  • Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 90:1977–1981

    Article  CAS  Google Scholar 

  • Strittmatter WJ et al (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 125:163–171

    Article  CAS  Google Scholar 

  • Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Jama 283:2008–2012

    Article  CAS  Google Scholar 

  • Tang M-X et al (2001) Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56:49–56

    Article  CAS  Google Scholar 

  • Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, Arrighi HM (2012) Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer’s disease: a systematic review and meta-analysis. Neuroepidemiology 38:1–17

    Article  Google Scholar 

  • Wells G, Shea B, O’Connell D, Peterson J, Welch V et al (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Dept of epidemiology and community medicine. University of Ottawa, Ottawa

    Google Scholar 

  • Winblad B et al (2016) Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol 15:455–532

    Article  Google Scholar 

  • Yu J-T, Tan L, Hardy J (2014) Apolipoprotein E in Alzheimer's disease: an update. Annu Rev Neurosci 37:79–100

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

    Morteza Abyadeh

  2. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Kurosh Djafarian & Shahab Alizadeh

  3. Department of Nursing, School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, Iran

    Fatemeh Heydarinejad

  4. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Sakineh Shab-Bidar

Authors
  1. Morteza Abyadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurosh Djafarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatemeh Heydarinejad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shahab Alizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sakineh Shab-Bidar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sakineh Shab-Bidar.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abyadeh, M., Djafarian, K., Heydarinejad, F. et al. Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis. J Mol Neurosci 69, 557–562 (2019). https://doi.org/10.1007/s12031-019-01381-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-019-01381-1

Keywords

Search

Navigation